Standards of practice for superficial femoral and popliteal artery angioplasty and stenting

CardioVascular and Interventional Radiology

Volumn 37, Issue 3, 2014, Pages 592-603

  Katsanos, Konstantinos ^a   Tepe, Gunnar ^b   Tsetis, Dimitris ^c   Fanelli, Fabrizio ^d  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b RoMed Clinical Centre Rosenheim   (Germany)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Angioplasty; Arteriosclerosis; Imaging; Popliteal artery; Stenting; Superficial femoral artery

Indexed keywords

ANGIOPLASTY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSERVATIVE TREATMENT; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG ELUTING STENT; DUPLEX ULTRASOUND; EUROPE; FALSE ANEURYSM; FISTULA; FOLLOW UP; GROIN HEMATOMA; HUMAN; IMAGING; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL DECISION MAKING; NITINOL STENT; NONHUMAN; PATIENT CARE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY STENT; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARD; SUPERFICIAL FEMORAL ARTERY STENT; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; ARTERIAL OCCLUSIVE DISEASES; FEMORAL ARTERY; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; STENT;

ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; FEMORAL ARTERY; HUMANS; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; STENTS;

EID: 84901641631     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-014-0876-3     Document Type: Review

References (81)

1. Kasapis C, Gurm HS (2009) Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev 5(4):296-311
2. Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31(1 Pt 2):S1-S296
3. Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1-S75 (Pubitemid 46068992)
4. Rooke TW, Hirsch AT, Misra S et al (2011) 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Vasc Surg 54(5):e32-e58
5. Tendera M, Aboyans V, Bartelink ML et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32(22):2851-2906
6. Tsetis D, Belli AM (2004) Guidelines for stenting in infrainguinal arterial disease. Cardiovasc Intervent Radiol 27(3):198-203 (Pubitemid 38864748)
7. Cassese S, Byrne RA, Ott I et al (2012) Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv 5(4):582-589
8. Dake MD, Ansel GM, Jaff MR et al (2011) Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4(5):495-504
9. Duda SH, Pusich B, Richter G et al (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106(12):1505-1509
10. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ (2008) Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19(6):823-832 (Pubitemid 351713526)
11. Schillinger M, Sabeti S, Loewe C et al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354(18):1879-1888 (Pubitemid 43872689)
12. Alonso-Coello P, Bellmunt S, McGorrian C et al (2012) Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e669S-e690S
13. Sixt S, Zeller T (2011) Summary of NICE guidance. Heart 97(24):2075-2077
14. Pentecost MJ, Criqui MH, Dorros G et al (2003) Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. J Vasc Interv Radiol 14(9 Pt 2):S495-S515
15. Criqui MH, Ninomiya JK, Wingard DL, Ji M, Fronek A (2008) Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 52(21):1736-1742
16. Criqui MH, Langer RD, Fronek A et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326(6):381-386
17. Slovut DP, Sullivan TM (2008) Critical limb ischemia: medical and surgical management. Vasc Med 13(3):281-291
18. Karnabatidis D, Spiliopoulos S, Tsetis D, Siablis D (2011) Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Cardiovasc Intervent Radiol 34(6):1123-1136
19. Fowkes FG, Murray GD, Butcher I et al (2008) Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300(2):197-208 (Pubitemid 351969304)
20. Allaqaband S, Kirvaitis R, Jan F, Bajwa T (2009) Endovascular treatment of peripheral vascular disease. Curr Probl Cardiol 34(9):359-476
21. Ledermann HP, Heidecker HG, Schulte AC et al (2006) Calf muscles imaged at BOLD MR: correlation with TcPO2 and flowmetry measurements during ischemia and reactive hyperemia-initial experience. Radiology 241(2):477-484 (Pubitemid 44632894)
22. Ladurner R, Kuper M, Konigsrainer I et al (2010) Predictive value of routine transcutaneous tissue oxygen tension (tcpO2) measurement for the risk of non-healing and amputation in diabetic foot ulcer patients with non-palpable pedal pulses. Med Sci Monit 16(6):CR273-CR277
23. Girolami B, Bernardi E, Prins MH et al (1999) Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med 159(4):337-345 (Pubitemid 29091621)
24. Mahmud E, Cavendish JJ, Salami A (2007) Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol 50(6):473-490 (Pubitemid 47126782)
25. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):7-22
26. Altenburg A, Haage P (2012) Antiplatelet and anticoagulant drugs in interventional radiology. Cardiovasc Intervent Radiol 35(1):30-42
27. Antithrombotic Trialists C (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71-86
28. CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348(9038):1329-1339
29. Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA (2009) Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 30(2):192-201
30. Bhatt DL, Flather MD, Hacke W et al (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49(19):1982-1988 (Pubitemid 46694290)
31. Girolami B, Bernardi E, Prins MH et al (2000) Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. Eur J Vasc Endovasc Surg 19(4):370-380 (Pubitemid 30232609)
32. Hankey GJ, Norman PE, Eikelboom JW (2006) Medical treatment of peripheral arterial disease. JAMA 295(5):547-553 (Pubitemid 43200349)
33. Alexandrescu V, Vincent G, Azdad K et al (2011) A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther 18(3):376-387
34. Peregrin JH, Koznar B, Kovac J et al (2010) PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 33(4):720-725
35. Baril DT, Marone LK (2012) Duplex evaluation following femoropopliteal angioplasty and stenting: criteria and utility of surveillance. Vasc Endovasc Surg 46(5):353-357
36. Langenberger H, Schillinger M, Plank C et al (2012) Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and in-stent SFA re-stenosis-findings from a randomized controlled trial. Eur J Radiol 81(9):2265-2269
37. Ouwendijk R, de Vries M, Stijnen T et al (2008) Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial. AJR Am J Roentgenol 190(5):1349-1357 (Pubitemid 351684929)
38. NICE (August 2012) Clinical Guideline 147: lower limb peripheral arterial disease: diagnosis and management. National Clinical Guideline Centre, http://www.nice.org.uk
39. Miyazaki M, Akahane M (2012) Non-contrast enhanced MR angiography: established techniques. J Magn Reson Imaging 35(1):1-19
40. Patel IJ, Davidson JC, Nikolic B et al (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23(6):727-736
41. Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21(12):2527-2541
42. Erselcan T, Egilmez H, Hasbek Z, Tandogan I (2012) Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients. Acta Radiol 53(2):228-232
43. Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J (2005) Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 12(6):685-695 (Pubitemid 43100926)
44. Gable D (2011) Role of total endoluminal superficial femoral artery bypass. J Cardiovasc Surg (Torino) 52(5):683-700
45. Fanelli F, Lucatelli P, Allegritti M, Corona M, Rossi P, Passariello R (2011) Retrograde popliteal access in the supine patient for recanalization of the superficial femoral artery: initial results. J Endovasc Ther 18(4):503-509
46. Gandini R, Fabiano S, Spano S et al (2012) Randomized control study of the outback ltd re-entry catheter vs. manual re-entry for the treatment of chronic total occlusions in the superficial femoral artery. Catheter Cardiovasc Interv 82(3):485-492
47. Gutzeit A, Graf N, Schoch E, Sautter T, Jenelten R, Binkert CA (2011) Ultrasound-guided antegrade femoral access: comparison between the common femoral artery and the superficial femoral artery. Eur Radiol 21(6):1323-1328
48. Bown MJ, Bolia A, Sutton AJ (2009) Subintimal angioplasty: meta-analytical evidence of clinical utility. Eur J Vasc Endovasc Surg 38(3):323-337
49. Bolia A, Brennan J, Bell PR (1989) Recanalisation of femoropopliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 40(3):325
50. Siablis D, Diamantopoulos A, Katsanos K et al (2012) Subintimal angioplasty of long chronic total femoropopliteal occlusions: long-term outcomes, predictors of angiographic restenosis, and role of stenting. Cardiovasc Intervent Radiol 35(3):483-490
51. Dick P, Wallner H, Sabeti S et al (2009) Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 74(7):1090-1095
52. Krankenberg H, Schluter M, Steinkamp HJ et al (2007) Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116(3):285-292 (Pubitemid 47196564)
53. Chalmers N, Walker PT, Belli AM, Thorpe AP, Sidhu PS, Robinson G, van Ransbeeck M, Fearn SA (2013) Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study. Cardiovasc Intervent Radiol 36(2):353-361
54. Perrio S, Holt PJ, Patterson BO, Hinchliffe RJ, Loftus IM, Thompson MM (2010) Role of superficial femoral artery stents in the management of arterial occlusive disease: review of current evidence. Vascular 18(2):82-92
55. Kasapis C, Henke PK, Chetcuti SJ et al (2009) Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 30(1):44-55
56. Shammas NW, Coiner D, Shammas G, Jerin M (2011) Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. Int J Angiol 20(2):95-100
57. Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL (2008) The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg 36(3):339-345
58. Scheinert D, Scheinert S, Sax J et al (2005) Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45(2):312-315 (Pubitemid 40094743)
59. Richter GM, Palmaz JC, Noeldge G, Tio F (1999) Relationship between blood flow, thrombus, and neointima in stents. J Vasc Interv Radiol 10(5):598-604 (Pubitemid 29232835)
60. Wainwright CL, Miller AM, Wadsworth RM (2001) Inflammation as a key event in the development of neointima following vascular balloon injury. Clin Exp Pharmacol Physiol 28(11):891-895 (Pubitemid 33071062)
61. Bhoday J, de Silva S, Xu Q (2006) The molecular mechanisms of vascular restenosis: which genes are crucial? Curr Vasc Pharmacol 4(3):269-275 (Pubitemid 46785493)
62. Schwartz RS, Huber KC, Murphy JG et al (1992) Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19(2):267-274
63. Duda SH, Bosiers M, Lammer J et al (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16(3):331-338 (Pubitemid 40354849)
64. Cioppa A, Stabile E, Popusoi G et al (2012) Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical results. Cardiovasc Revasc Med 13(4):219-223
65. Zeller T, Krankenberg H, Steinkamp H et al (2009) One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther 16(6):653-662
66. Khaghany K, Al-Ali F, Spigelmoyer T, Pimentel R, Wharton K (2005) Efficacy and safety of the perclose closer s device after neurointerventional procedures: prospective study and literature review. AJNR Am J Neuroradiol 26(6):1420-1424 (Pubitemid 43733440)
67. Upponi SS, Ganeshan AG, Warakaulle DR, Phillips-Hughes J, Boardman P, Uberoi R (2007) Angioseal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures-a randomized controlled trial. Eur J Radiol 61(2):332-334 (Pubitemid 46096683)
68. Zalunardo B, Tonello D, Busato F, Zotta L, Irsara S, Visona A (2012) Antithrombotic therapy after peripheral angioplasty, various techniques and challenges in treatment of congenital and acquired vascular stenoses, Dr. Thomas Forbes (Ed.), ISBN: 978-953-51-0084-3, InTech
69. Tepe G, Bantleon R, Brechtel K et al (2012) Management of peripheral arterial interventions with mono or dual antiplatelet therapy - the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol 22(9):1998-2006
70. Spiliopoulos S, Pastromas G, Katsanos K, Kitrou P, Karnabatidis D, Siablis D (2013) Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP Study: Clinical Impact and Optimal Cutoff Value of On-Treatment High Platelet Reactivity. J Am Coll Cardiol 61(24):2428-2434
71. Muradin GS, Bosch JL, Stijnen T, Hunink MG (2001) Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221(1):137-145 (Pubitemid 32880382)
72. Acin F, de Haro J, Bleda S, Varela C, Esparza L (2012) Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther 19(5):585-595
73. Duda SH, Bosiers M, Lammer J et al (2006) Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13(6):701-710 (Pubitemid 44907633)
74. Spiliopoulos S, Katsanos K, Karnabatidis D et al (2010) Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial. Cardiovasc Intervent Radiol 33(5):929-938
75. Samson RH, Showalter DP, Lepore M Jr, Nair DG, Merigliano K (2008) CryoPlasty therapy of the superficial femoral and popliteal arteries: a reappraisal after 44 months' experience. J Vasc Surg 48(3):634-637
76. Axisa B, Fishwick G, Bolia A et al (2002) Complications following peripheral angioplasty. Ann R Coll Surg Engl 84(1):39-42 (Pubitemid 34071158)
77. Kearns BC, Michaels JA, Stevenson MD, Thomas SM (2013) Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease. Br J Surg 100(9):1180-1188
78. Tsetis D, Belli AM (2004) The role of infrapopliteal angioplasty. Br J Radiol 77(924):1007-1015 (Pubitemid 40057797)
79. Owen AR, Roditi GH (2011) Peripheral arterial disease: the evolving role of non-invasive imaging. Postgrad Med J 87(1025):189-198
80. Sacks D, Marinelli DL, Martin LG, Spies JB (1997) Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. Technology Assessment Committee. J Vasc Interv Radiol 8(1 Pt 1):137-149 (Pubitemid 27522864)
81. Karnabatidis D, Katsanos K, Kagadis GC et al (2006) Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovasc Ther 13(3):269-280 (Pubitemid 44775201)